Published in Am Rev Respir Dis on March 01, 1990
Mechanisms of virus induced exacerbations of asthma. Thorax (1997) 1.12
Perception of bronchial obstruction in asthmatic patients. Relationship with bronchial eosinophilic inflammation and epithelial damage and effect of corticosteroid treatment. J Clin Invest (1995) 1.08
Comparative nasal effects of bradykinin, kallidin and [Des-Arg9]-bradykinin in atopic rhinitic and normal volunteers. J Physiol (1991) 1.06
Bradykinin and asthma. Thorax (1992) 0.92
Comparative nasal effects of bradykinin and histamine: influence on nasal airways resistance and plasma protein exudation. Thorax (1993) 0.85
Attenuation of human nasal airway responses to bradykinin and histamine by inhibitors of nitric oxide synthase. Br J Pharmacol (1996) 0.80
Immunohistochemical localization of the bradykinin B1 and B2 receptors in human nasal mucosa. Mediators Inflamm (2009) 0.80
Bradykinin stimulates MMP-2 production in guinea pig tracheal smooth muscle cells. Inflammation (2003) 0.77
Acute effect of inhaled bradykinin on tracheobronchial clearance in normal humans. Thorax (1992) 0.75
Specific immunotherapy with mugwort pollen allergoid reduce bradykinin release into the nasal fluid. Postepy Dermatol Alergol (2016) 0.75
The temporal relationship between the neural and vascular actions of kallidin within the nose. Mediators Inflamm (1993) 0.75
CD4+ count-guided interruption of antiretroviral treatment. N Engl J Med (2006) 22.76
Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy (2008) 12.35
Decline in the AIDS and death rates in the EuroSIDA study: an observational study. Lancet (2003) 7.94
Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group. Lancet (1998) 7.53
Interleukin-2 therapy in patients with HIV infection. N Engl J Med (2009) 4.38
Profound but reversible myocardial depression in patients with septic shock. Ann Intern Med (1984) 3.81
Risk for opportunistic disease and death after reinitiating continuous antiretroviral therapy in patients with HIV previously receiving episodic therapy: a randomized trial. Ann Intern Med (2008) 3.68
Anaemia is an independent predictive marker for clinical prognosis in HIV-infected patients from across Europe. EuroSIDA study group. AIDS (1999) 3.67
CD4 counts as predictors of opportunistic pneumonias in human immunodeficiency virus (HIV) infection. Ann Intern Med (1989) 3.13
HIV viral load response to antiretroviral therapy according to the baseline CD4 cell count and viral load. JAMA (2001) 2.95
Changes in the cause of death among HIV positive subjects across Europe: results from the EuroSIDA study. AIDS (2002) 2.90
Effects of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of AIDS-associated P. carinii pneumonia. Lancet (1999) 2.80
Immunological release of histamine and slow reacting substance of anaphylaxis from human lung. II. Influence of cellular levels of cyclic AMP. Fed Proc (1972) 2.55
Predictors of virological success and ensuing failure in HIV-positive patients starting highly active antiretroviral therapy in Europe: results from the EuroSIDA study. Arch Intern Med (2000) 2.49
Dendritic cells with antigen-presenting capability reside in airway epithelium, lung parenchyma, and visceral pleura. J Exp Med (1986) 2.45
An objective case definition of lipodystrophy in HIV-infected adults: a case-control study. Lancet (2003) 2.43
Role of circulating nitrite and S-nitrosohemoglobin in the regulation of regional blood flow in humans. Proc Natl Acad Sci U S A (2000) 2.41
Improved diagnosis of Pneumocystis carinii infection by polymerase chain reaction on induced sputum and blood. Lancet (1992) 2.40
The use of the Framingham equation to predict myocardial infarctions in HIV-infected patients: comparison with observed events in the D:A:D Study. HIV Med (2006) 2.38
Pneumocystis carinii pneumonia: a major complication of immunosuppressive therapy in patients with Wegener's granulomatosis. Am J Respir Crit Care Med (1995) 2.31
Lipid profiles in HIV-infected patients receiving combination antiretroviral therapy: are different antiretroviral drugs associated with different lipid profiles? J Infect Dis (2004) 2.26
A circulating myocardial depressant substance in humans with septic shock. Septic shock patients with a reduced ejection fraction have a circulating factor that depresses in vitro myocardial cell performance. J Clin Invest (1985) 2.26
Influence of age on CD4 cell recovery in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy: evidence from the EuroSIDA study. J Infect Dis (2001) 2.19
Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs. J Allergy Clin Immunol (2012) 2.17
AIDS across Europe, 1994-98: the EuroSIDA study. Lancet (2000) 2.13
Update on Pneumocystis carinii f. sp. hominis typing based on nucleotide sequence variations in internal transcribed spacer regions of rRNA genes. J Clin Microbiol (1998) 2.11
Trimetrexate for the treatment of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. N Engl J Med (1987) 2.05
Effects of inhaled nitric oxide on regional blood flow are consistent with intravascular nitric oxide delivery. J Clin Invest (2001) 2.03
Loss of T-cell receptor zeta chain and p56lck in T-cells infiltrating human renal cell carcinoma. Cancer Res (1993) 2.01
Cardio- and cerebrovascular events in HIV-infected persons. AIDS (2004) 1.98
Survival of AIDS patients according to type of AIDS-defining event. The AIDS in Europe Study Group. Int J Epidemiol (1997) 1.97
Discontinuation of Pneumocystis carinii pneumonia prophylaxis after start of highly active antiretroviral therapy in HIV-1 infection. EuroSIDA Study Group. Lancet (1999) 1.95
The incidence of AIDS-defining illnesses at a current CD4 count ≥ 200 cells/μL in the post-combination antiretroviral therapy era. Clin Infect Dis (2013) 1.91
Serial cardiovascular variables in survivors and nonsurvivors of human septic shock: heart rate as an early predictor of prognosis. Crit Care Med (1987) 1.89
Slow-reacting substances, leukotrienes C4 and D4, increase the release of mucus from human airways in vitro. Am Rev Respir Dis (1982) 1.89
Takayasu's arteritis and its therapy. Ann Intern Med (1985) 1.82
Characterization of a monoclonal antibody that defines an immunoregulatory T cell subset for immunoglobulin synthesis in humans. Proc Natl Acad Sci U S A (1980) 1.81
Relative role of heme nitrosylation and beta-cysteine 93 nitrosation in the transport and metabolism of nitric oxide by hemoglobin in the human circulation. Proc Natl Acad Sci U S A (2000) 1.81
Health consequences associated with frequent wheezing in adolescents without asthma diagnosis. Eur Respir J (2003) 1.77
Loss to follow-up in an international, multicentre observational study. HIV Med (2008) 1.70
Variable mutations of the RB gene in small-cell lung carcinoma. Oncogene (1990) 1.63
Induced sputum to diagnose Pneumocystis carinii pneumonia in immunosuppressed pediatric patients. J Pediatr (1989) 1.63
Leukotriene B4 and interleukin-8 in human immunodeficiency virus-related pulmonary disease. Chest (1993) 1.62
Adult respiratory distress syndrome in patients with severe neutropenia. N Engl J Med (1986) 1.60
The pathophysiology of rhinitis. II. Assessment of the sources of protein in histamine-induced nasal secretions. Am Rev Respir Dis (1989) 1.55
Effects of arachidonic acid, monohydroxyeicosatetraenoic acid and prostaglandins on the release of mucous glycoproteins from human airways in vitro. J Clin Invest (1981) 1.52
Clinical characteristics of Japanese patients with primary myelodysplastic syndromes: a co-operative study based on 838 cases. Anemia Study Group of the Ministry of Health and Welfare. Leuk Res (1995) 1.48
The case for indicator condition-guided HIV screening. HIV Med (2013) 1.48
Prognostic factors and life expectancy of patients with acquired immunodeficiency syndrome and Pneumocystis carinii pneumonia. Am Rev Respir Dis (1987) 1.47
Cyclic adenosine 3',5'-monophosphate in human lung. Biochim Biophys Acta (1971) 1.44
Successful treatment of refractory anemia with high-dose methylprednisolone. Am J Hematol (1990) 1.41
The effects of heterologous platelet transfusion on pulmonary function during ARDS. Chest (1990) 1.39
Immunologic and neuropharmacologic stimulation of mucous glycoprotein release from human airways in vitro. J Clin Invest (1980) 1.39
Tumor necrosis factor-alpha induces mucin hypersecretion and MUC-2 gene expression by human airway epithelial cells. Am J Respir Cell Mol Biol (1995) 1.38
Biological properties of HIV isolates in primary HIV infection: consequences for the subsequent course of infection. AIDS (1993) 1.36
Human monoclonal anti-keyhole limpet hemocyanin antibody-secreting hybridoma produced from peripheral blood B lymphocytes of a keyhole limpet hemocyanin-immune individual. J Exp Med (1982) 1.36
A comparison of exposure groups in the EuroSIDA study: starting highly active antiretroviral therapy (HAART), response to HAART, and survival. J Acquir Immune Defic Syndr (1999) 1.35
Alpha-adrenergic hyper-responsiveness in asthma. N Engl J Med (1979) 1.35
A circulating myocardial depressant substance is associated with cardiac dysfunction and peripheral hypoperfusion (lactic acidemia) in patients with septic shock. Chest (1989) 1.34
Reasons for stopping antiretrovirals used in an initial highly active antiretroviral regimen: increased incidence of stopping due to toxicity or patient/physician choice in patients with hepatitis C coinfection. AIDS Res Hum Retroviruses (2005) 1.34
Identification of Pneumocystis carinii chromosomes and mapping of five genes. Infect Immun (1990) 1.34
Alterations in T cell receptor and signal transduction molecules in melanoma patients. Clin Cancer Res (1995) 1.33
Longitudinal serum HIV RNA quantification: correlation to viral phenotype at seroconversion and clinical outcome. AIDS (1996) 1.32
Time to virological failure of 3 classes of antiretrovirals after initiation of highly active antiretroviral therapy: results from the EuroSIDA study group. J Infect Dis (2004) 1.31
Diagnostic use of PCR for detection of Pneumocystis carinii in oral wash samples. J Clin Microbiol (1998) 1.31
gamma-Glutamyl dopa: a kidney-specific dopamine precursor. J Pharmacol Exp Ther (1978) 1.30
Chromosome band 1p36 contains a putative tumor suppressor gene important in the evolution of chronic myelocytic leukemia. Blood (1998) 1.30
Relations among CD4 lymphocyte count nadir, antiretroviral therapy, and HIV-1 disease progression: results from the EuroSIDA study. Ann Intern Med (1999) 1.30
A new technique for the cytochemical examination of human hemopoietic cells grown in agar gel. Exp Hematol (1980) 1.29
Updated European recommendations for the clinical use of HIV drug resistance testing. Antivir Ther (2004) 1.28
Temporal changes and regional differences in treatment uptake of hepatitis C therapy in EuroSIDA. HIV Med (2013) 1.28
Discontinuation of secondary prophylaxis against Pneumocystis carinii pneumonia in patients with HIV infection who have a response to antiretroviral therapy. Eight European Study Groups. N Engl J Med (2001) 1.27
Pathophysiology of rhinitis. Lactoferrin and lysozyme in nasal secretions. J Clin Invest (1989) 1.24
Development and implementation of guidelines in allergic rhinitis – an ARIA-GA2LEN paper. Allergy (2010) 1.24
Autonomic nervous system abnormalities and allergy. Ann Intern Med (1982) 1.22
Prognostic markers of short-term mortality in AIDS-associated Pneumocystis carinii pneumonia. Chest (2001) 1.21
A point mutation at codon 13 of the N-ras oncogene in myelodysplastic syndrome. Nature (1987) 1.20
Epidemiology of cryptosporidiosis among European AIDS patients. Genitourin Med (1996) 1.20
Human airway monohydroxyeicosatetraenoic acid generation and mucus release. J Clin Invest (1983) 1.20
Parameters for the diagnosis and management of sinusitis. J Allergy Clin Immunol (1998) 1.19
Persistence of Pneumocystis carinii in lung tissue of acquired immunodeficiency syndrome patients treated for pneumocystis pneumonia. Am Rev Respir Dis (1984) 1.19
Neutrophil attractant/activation protein-1 (NAP-1) causes human basophil histamine release. Immunol Lett (1989) 1.19
Response to antiretroviral therapy among patients exposed to three classes of antiretrovirals: results from the EuroSIDA study. Antivir Ther (2002) 1.19
Interruption of combination antiretroviral therapy and risk of clinical disease progression to AIDS or death. HIV Med (2007) 1.17
Nosocomial outbreak of cryptosporidiosis in AIDS patients. BMJ (1991) 1.16
Detection of novel germ-line p53 mutations in diverse-cancer-prone families identified by selecting patients with childhood adrenocortical carcinoma. J Natl Cancer Inst (1992) 1.16
Inhaled nitric oxide augments nitric oxide transport on sickle cell hemoglobin without affecting oxygen affinity. J Clin Invest (1999) 1.15
Evaluation of HIV protease inhibitor use and the risk of sudden death or nonhemorrhagic stroke. J Infect Dis (2012) 1.13
Estimation of nasal epithelial lining fluid using urea as a marker. J Allergy Clin Immunol (1993) 1.12
Dexamethasone alters arachidonate release from human epithelial cells by induction of p11 protein synthesis and inhibition of phospholipase A2 activity. J Biol Chem (1999) 1.12
Virtual bronchoscopy: segmentation method for real-time display. Radiology (1996) 1.11
HIV in the UK 1980-2006: reconstruction using a model of HIV infection and the effect of antiretroviral therapy. HIV Med (2007) 1.11
Bacterial lipopolysaccharides prime human neutrophils for enhanced production of leukotriene B4. J Clin Invest (1989) 1.11
Alterations of the p53 gene are common and critical events for the maintenance of malignant phenotypes in small-cell lung carcinoma. Oncogene (1992) 1.10
Depressed left ventricular performance. Response to volume infusion in patients with sepsis and septic shock. Chest (1988) 1.09
Antibody responses to a major Pneumocystis carinii antigen in human immunodeficiency virus-infected patients with and without P. carinii pneumonia. J Infect Dis (1992) 1.09
Efficacy of ascorbic acid in Chediak-Higashi syndrome (CHS): studies in humans and mice. Blood (1979) 1.08